- Marburg virus
-
Marburg virus (MARV) Virus classification Group: Group V ((-)ssRNA) Order: Mononegavirales Family: Filoviridae Genus: Marburgvirus Species: Marburg marburgvirus (accepted) Marburg virus (MARV) causes severe disease in humans and nonhuman primates in the form of viral hemorrhagic fever. MARV is a Select Agent,[1] World Health Organization Risk Group 4 Pathogen (requiring Biosafety Level 4-equivalent containment),[2] National Institutes of Health/National Institute of Allergy and Infectious Diseases Category A Priority Pathogen,[3] Centers for Disease Control and Prevention Category A Bioterrorism Agent,[4] and is listed as a Biological Agent for Export Control by the Australia Group.[5]
Contents
Use of term
Marburg virus (abbreviated MARV) was first described in 1967.[6] Today, the virus is one of two members of the species Marburg marburgvirus, which is included into the genus Marburgvirus, family Filoviridae, order Mononegavirales. The name Marburg virus is derived from Marburg (the city in Hesse, West Germany, where the virus was first discovered) and the taxonomic suffix virus.[7]
Note
Marburg virus is pronounced ˌmɑrbərg vɑɪrəs (IPA) or mahr-berg vahy-ruhs in English phonetic notation.[7] According to the rules for taxon naming established by the International Committee on Taxonomy of Viruses (ICTV), the name Marburg virus is always to be capitalized, but is never italicized, and may be abbreviated (with MARV being the official abbreviation).
Previous designations
Marburg virus was first introduced under this name in 1967.[6] In 2005, the virus name was changed to Lake Victoria marburgvirus, which unfortunately was the same spelling as the species Lake Victoria marburgvirus.[8][9] However, most scientific articles continued to refer to Marburg virus. Consequently, in 2010, the name Marburg virus was reinstated.[7] A previous abbreviation for the virus was MBGV.
Virus inclusion criteria
A virus that fulfills the criteria for being a member of the species Marburg marburgvirus is a Marburg virus if its genome diverges from that of the prototype Marburg marburgvirus, Marburg virus variant Musoke (MARV/Mus), by <10% at the nucleotide level.[7]
Disease
Main article: Marburg virus diseaseMARV is one of two marburgviruses that causes Marburg virus disease (MVD) in humans (in the literature also often referred to as Marburg hemorrhagic fever, MHF). In the past, MARV has caused the following MVD outbreaks:
Marburg virus disease (MVD) outbreaks due to Marburg virus (MARV) infection Year Geographic location Human cases/deaths (case-fatality rate) 1967 Marburg and Frankfurt, West Germany, and Belgrade, Yugoslavia 7/31 (23%)[6][10][11][12][13][14][15][16] 1975 Rhodesia and Johannesburg, South Africa 1/3 (33%)[17][18][19] 1980 Kenya 1/2 (50%)[20] 1987 Kenya 1/1 (100%)[21][22] 1988 Koltsovo, Soviet Union 1/1 (100%) [laboratory accident][23] 1990 Koltsovo, Soviet Union 0/1 (0%) [laboratory accident]][24] 1998-2000 Durba and Watsa, Democratic Republic of the Congo ? (A total of 154 cases and 128 deaths of marburgvirus infection were recorded during this outbreak. The case fatality was 83%. Two different marburgviruses, MARV and Ravn virus (RAVV), cocirculated and caused disease. It has never been published how many cases and deaths were due to MARV or RAVV infection)[25][26][27] 2004-2005 Angola 227/252 (90%)[28][29][30][31][32][33][34] 2007 Uganda 1/3 (33%)%)[35][36] 2008 Uganda, Netherlands 1/1 (100%)[37] Virology
Genome
Like all mononegaviruses, marburgvirions contain non-infectious, linear nonsegmented, single-stranded RNA genomes of negative polarity that possesses inverse-complementary 3' and 5' termini, do not possess a 5' cap, are not polyadenylated, and are not covalently linked to a protein.[38] Marburgvirus genomes are approximately 19 kb long and contain seven genes in the order 3'-UTR-NP-VP35-VP40-GP-VP30-VP24-L-5'-UTR.[39] The genomes of the two different marburgviruses (MARV and RAVV) differ in sequence.
Structure
Like all filoviruses, marburgvirions are filamentous particles that may appear in the shape of a shepherd's crook or in the shape of a "U" or a "6", and they may be coiled, toroid, or branched.[39] Marburgvirions are generally 80 nm in width, but vary somewhat in length. In general, the median particle length of marburgviruses ranges from 795-828 nm (in contrast to ebolavirions, whose median particle length was measured to be 974-1,086 nm ), but particles as long as 14,000 nm have been detected in tissue culture.[40]. Marburgvirions consist of seven structural proteins. At the center is the helical ribonucleocapsid, which consists of the genomic RNA wrapped around a polymer of nucleoproteins (NP). Associated with the ribonucleoprotein is the RNA-dependent RNA polymerase (L) with the polymerase cofactor (VP35) and a transcription activator (VP30). The ribonucleoprotein is embedded in a matrix, formed by the major (VP40) and minor (VP24) matrix proteins. These particles are surrounded by a lipid membrane derived from the host cell membrane. The membrane anchors a glycoprotein (GP1,2) that projects 7 to 10 nm spikes away from its surface. While nearly identical to ebolavirions in structure, marburgvirions are antigenically distinct.
Replication
The marburgvirus life cycle begins with virion attachment to specific cell-surface receptors, followed by fusion of the virion envelope with cellular membranes and the concomitant release of the virus nucleocapsid into the cytosol. The virus RdRp partially uncoats the nucleocapsid and transcribes the genes into positive-stranded mRNAs, which are then translated into structural and nonstructural proteins. Marburgvirus L binds to a single promoter located at the 3' end of the genome. Transcription either terminates after a gene or continues to the next gene downstream. This means that genes close to the 3' end of the genome are transcribed in the greatest abundance, whereas those toward the 5' end are least likely to be transcribed. The gene order is therefore a simple but effective form of transcriptional regulation. The most abundant protein produced is the nucleoprotein, whose concentration in the cell determines when L switches from gene transcription to genome replication. Replication results in full-length, positive-stranded antigenomes that are in turn transcribed into negative-stranded virus progeny genome copies. Newly synthesized structural proteins and genomes self-assemble and accumulate near the inside of the cell membrane. Virions bud off from the cell, gaining their envelopes from the cellular membrane they bud from. The mature progeny particles then infect other cells to repeat the cycle.[8]
Ecology
In 2009, the successful isolation of infectious MARV was reported from caught healthy Egyptian rousettes (Rousettus aegyptiacus).[35] This isolation, together with the isolation of infectious RAVV,[35] strongly suggests that Old World fruit bats are involved in the natural maintenance of marburgviruses. Further studies are necessary to establish whether Egyptian rousettes are the actual hosts of MARV and RAVV or whether they get infected via contact with another animal and therefore serve only as intermediate hosts.
Weaponization
The Soviet Union had an extensive offensive and defensive biological weapons program that included MARV.[41] At least three Soviet research institutes had MARV research programs during offensive times: the Virology Center of the Scientific-Research Institute for Microbiology in Zagorsk (today Sergiev Posad), the Scientific-Production Association "Vektor" (today the State Research Center of Virology and Biotechnology "Vektor") in Koltsovo, and the Irkutsk Scientific-Research Anti-Plague Institute of Siberia and the Far East in Irkutsk. As most performed research was highly classified, it remains unclear how successful the MARV program was. However, Soviet defector Ken Alibek claimed that a weapon filled with MARV was tested at the Stepnogorsk Scientific Experimental and Production Base in Stepnogorsk, Kazakh Soviet Socialist Republic (today Kazakhstan),[41] suggesting that the development of a MARV biological weapon had reached advanced stages. Independent confirmation for this claim is lacking. At least one laboratory accident with MARV, resulting in the death of Koltsovo researcher Nikolai Ustinov, occurred during offensive times in the Soviet Union and was first described in detail by Alibek.[41] After the collapse of the Soviet Union, MARV research continued in all three institutes, but judging from published material this research has been defensive in nature.
Popular culture
- In the non-fiction thriller, The Hot Zone, Richard Preston describes several MARV infections
- In the TV series Millennium, at the end of Season 2, a "prion version" of MARV causes a disease outbreak in Seattle, killing (amongst others) Frank Black's wife, Catherine. In the Season 3 episode Collateral Damage, Peter Watt's daughter is infected with MARV by a Gulf War veteran who claims that the Millennium Group did the same to American soldiers during the first Gulf War
- In the crossover event of the TV series Medical Investigation, episode 17, and Third Watch, season 6 episode 16, Marburg virus disease breaks out in New York City, killing 5 of 6 infected people
- In the Sarah Jane Smith series (Series Two), MARV is used as a weapon by a doomsday cult
- In the short story Hell Hath Enlarged Herself by Michael Marshall Smith, one of the original scientists is infected with MARV in an attempt to test ImmunityWorks ver. 1.0
- In the novel Microserfs by Douglas Coupland, MARV is mentioned several times as a metaphor for the spread of information through the internet
- In the novel Resident Evil: Caliban Cove an insane scientist and former professor named Nicolas Griffith is referred to by Rebecca Chambers as having infected three men with MARV after they had been led to believe it was a harmless common cold virus
- In the novel Pandora's Legion by Harold Coyle and Barrett Tillman, an Al-Qaeda cell in Pakistan injects volunteers with MARV, who then board flights to major international airports in the western world where the large flow of people would facilitate the spreading of the virus into a pandemic.
References
- ^ US Animal and Plant Health Inspection Service (APHIS) and US Centers for Disease Control and Prevention (CDC). "National Select Agent Registry (NSAR)". http://www.selectagents.gov. Retrieved 2011-10-16.
- ^ US Department of Health and Human Services. "Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition". http://www.cdc.gov/biosafety/publications/bmbl5/. Retrieved 2011-10-16.
- ^ US National Institutes of Health (NIH), US National Institute of Allergy and Infectious Diseases (NIAID). "Biodefense - NIAID Category A, B, and C Priority Pathogens". http://www.niaid.nih.gov/topics/biodefenserelated/biodefense/research/pages/cata.aspx. Retrieved 2011-10-16.
- ^ US Centers for Disease Control and Prevention (CDC). "Bioterrorism Agents/Diseases". http://www.bt.cdc.gov/agent/agentlist-category.asp. Retrieved 2011-10-16.
- ^ The Australia Group. "List of Biological Agents for Export Control". http://www.australiagroup.net/en/biological_agents.html. Retrieved 2011-10-16.
- ^ a b c Siegert, R.; Shu, H. L.; Slenczka, W.; Peters, D.; Müller, G. (2009). "Zur Ätiologie einer unbekannten, von Affen ausgegangenen menschlichen Infektionskrankheit". DMW - Deutsche Medizinische Wochenschrift 92 (51): 2341–2343. doi:10.1055/s-0028-1106144. PMID 4294540.
- ^ a b c d Kuhn, J. H.; Becker, S.; Ebihara, H.; Geisbert, T. W.; Johnson, K. M.; Kawaoka, Y.; Lipkin, W. I.; Negredo, A. I. et al. (2010). "Proposal for a revised taxonomy of the family Filoviridae: Classification, names of taxa and viruses, and virus abbreviations". Archives of Virology 155 (12): 2083–2103. doi:10.1007/s00705-010-0814-x. PMC 3074192. PMID 21046175. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3074192.
- ^ a b Feldmann, H.; Geisbert, T. W.; Jahrling, P. B.; Klenk, H.-D.; Netesov, S. V.; Peters, C. J.; Sanchez, A.; Swanepoel, R. et al. (2005), "Family Filoviridae", in Fauquet, C. M.; Mayo, M. A.; Maniloff, J. et al., Virus Taxonomy—Eighth Report of the International Committee on Taxonomy of Viruses, San Diego, USA: Elsevier/Academic Press, pp. 645-653, ISBN 0123702003
- ^ Mayo, M. A. (2002). "ICTV at the Paris ICV: results of the plenary session and the binomial ballot". Archives of Virology 147 (11): 2254–60.
- ^ Smith, C. E.; Simpson, D. I.; Bowen, E. T.; Zlotnik, I. (1967). "Fatal human disease from vervet monkeys". Lancet 2 (7526): 1119–1121. PMID 4168558.
- ^ Kissling, R. E.; Robinson, R. Q.; Murphy, F. A.; Whitfield, S. G. (1968). "Agent of disease contracted from green monkeys". Science 160 (830): 888–890. PMID 4296724.
- ^ Martini, G. A.; Knauff, H. G.; Schmidt, H. A.; Mayer, G.; Baltzer, G. (2009). "Über eine bisher unbekannte, von Affen eingeschleppte Infektionskrankheit: Marburg-Virus-Krankheit". DMW - Deutsche Medizinische Wochenschrift 93 (12): 559–571. doi:10.1055/s-0028-1105098. PMID 4966280.
- ^ Stille, W.; Böhle, E.; Helm, E.; Van Rey, W.; Siede, W. (2009). "Über eine durch Cercopithecus aethiops übertragene Infektionskrankheit". DMW – Deutsche Medizinische Wochenschrift 93 (12): 572–582. doi:10.1055/s-0028-1105099. PMID 4966281.
- ^ Bonin, O. (1969). "The Cercopithecus monkey disease in Marburg and Frankfurt (Main), 1967". Acta zoologica et pathologica Antverpiensia 48: 319–331. PMID 5005859.
- ^ Jacob, H.; Solcher, H. (1968). "An infectious disease transmitted by Cercopithecus aethiops ("marbury disease") with glial nodule encephalitis". Acta neuropathologica 11 (1): 29–44. PMID 5748997.
- ^ Stojkovic, L.; Bordjoski, M.; Gligic, A.; Stefanovic, Z. (1971), "Two Cases of Cercopithecus-Monkeys-Associated Haemorrhagic Fever", in Martini, G. A.; Siegert, R., Marburg Virus Disease, Berlin, Germany: Springer-Verlag, pp. 24-33, ISBN 978-0387051994
- ^ Gear, J. S.; Cassel, G. A.; Gear, A. J.; Trappler, B.; Clausen, L.; Meyers, A. M.; Kew, M. C.; Bothwell, T. H. et al. (1975). "Outbreake of Marburg virus disease in Johannesburg". British medical journal 4 (5995): 489–493. PMC 1675587. PMID 811315. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1675587.
- ^ Gear, J. H. (1977). "Haemorrhagic fevers of Africa: An account of two recent outbreaks". Journal of the South African Veterinary Association 48 (1): 5–8. PMID 406394.
- ^ Conrad, J. L.; Isaacson, M.; Smith, E. B.; Wulff, H.; Crees, M.; Geldenhuys, P.; Johnston, J. (1978). "Epidemiologic investigation of Marburg virus disease, Southern Africa, 1975". The American journal of tropical medicine and hygiene 27 (6): 1210–1215. PMID 569445.
- ^ Smith, D. H.; Johnson, B. K.; Isaacson, M.; Swanapoel, R.; Johnson, K. M.; Killey, M.; Bagshawe, A.; Siongok, T. et al. (1982). "Marburg-virus disease in Kenya". Lancet 1 (8276): 816–820. PMID 6122054.
- ^ Marburg and Ebola viruses; Advances in Virus Research; Volume 47, 1996, Pages 1-52
- ^ Known Cases and Outbreaks of Marburg Hemorrhagic Fever, in Chronological Order
- ^ Beer, B.; Kurth, R.; Bukreyev, A. (1999). "Characteristics of Filoviridae: Marburg and Ebola viruses". Die Naturwissenschaften 86 (1): 8–17. PMID 10024977.
- ^ Nikiforov, V. V.; Turovskiĭ, I.; Kalinin, P. P.; Akinfeeva, L. A.; Katkova, L. R.; Barmin, V. S.; Riabchikova, E. I.; Popkova, N. I. et al. (1994). "A case of a laboratory infection with Marburg fever". Zhurnal mikrobiologii, epidemiologii, i immunobiologii (3): 104–106. PMID 7941853.
- ^ Bertherat, E.; Talarmin, A.; Zeller, H. (1999). "Democratic Republic of the Congo: Between civil war and the Marburg virus. International Committee of Technical and Scientific Coordination of the Durba Epidemic". Medecine tropicale : revue du Corps de sante colonial 59 (2): 201–204. PMID 10546197.
- ^ Bausch, D. G.; Borchert, M.; Grein, T.; Roth, C.; Swanepoel, R.; Libande, M. L.; Talarmin, A.; Bertherat, E. et al. (2003). "Risk Factors for Marburg Hemorrhagic Fever, Democratic Republic of the Congo". Emerging infectious diseases 9 (12): 1531–1537. PMC 3034318. PMID 14720391. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3034318.
- ^ Bausch, D. G.; Nichol, S. T.; Muyembe-Tamfum, J. J.; Borchert, M.; Rollin, P. E.; Sleurs, H.; Campbell, P.; Tshioko, F. K. et al. (2006). "Marburg Hemorrhagic Fever Associated with Multiple Genetic Lineages of Virus". New England Journal of Medicine 355 (9): 909–919. doi:10.1056/NEJMoa051465. PMID 16943403.
- ^ Hovette, P. (2005). "Epidemic of Marburg hemorrhagic fever in Angola". Medecine tropicale : revue du Corps de sante colonial 65 (2): 127–128. PMID 16038348.
- ^ Ndayimirije, N.; Kindhauser, M. K. (2005). "Marburg Hemorrhagic Fever in Angola — Fighting Fear and a Lethal Pathogen". New England Journal of Medicine 352 (21): 2155–2157. doi:10.1056/NEJMp058115. PMID 15917379.
- ^ Towner, J. S.; Khristova, M. L.; Sealy, T. K.; Vincent, M. J.; Erickson, B. R.; Bawiec, D. A.; Hartman, A. L.; Comer, J. A. et al. (2006). "Marburgvirus Genomics and Association with a Large Hemorrhagic Fever Outbreak in Angola". Journal of Virology 80 (13): 6497–6516. doi:10.1128/JVI.00069-06. PMC 1488971. PMID 16775337. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1488971.
- ^ Jeffs, B.; Roddy, P.; Weatherill, D.; De La Rosa, O.; Dorion, C.; Iscla, M.; Grovas, I.; Palma, P. P. et al. (2007). "The Médecins Sans Frontières Intervention in the Marburg Hemorrhagic Fever Epidemic, Uige, Angola, 2005. I. Lessons Learned in the Hospital". The Journal of Infectious Diseases 196: S154–S161. doi:10.1086/520548. PMID 17940944.
- ^ Roddy, P.; Weatherill, D.; Jeffs, B.; Abaakouk, Z.; Dorion, C.; Rodriguez‐Martinez, J.; Palma, P. P.; De La Rosa, O. et al. (2007). "The Médecins Sans Frontières Intervention in the Marburg Hemorrhagic Fever Epidemic, Uige, Angola, 2005. II. Lessons Learned in the Community". The Journal of Infectious Diseases 196: S162–S167. doi:10.1086/520544. PMID 17940945.
- ^ Roddy, P.; Marchiol, A.; Jeffs, B.; Palma, P. P.; Bernal, O.; De La Rosa, O.; Borchert, M. (2009). "Decreased peripheral health service utilisation during an outbreak of Marburg haemorrhagic fever, Uíge, Angola, 2005". Transactions of the Royal Society of Tropical Medicine and Hygiene 103 (2): 200–202. doi:10.1016/j.trstmh.2008.09.001. PMID 18838150.
- ^ Roddy, P.; Thomas, S. L.; Jeffs, B.; Nascimento Folo, P.; Pablo Palma, P.; Moco Henrique, B.; Villa, L.; Damiao Machado, F. P. et al. (2010). "Factors Associated with Marburg Hemorrhagic Fever: Analysis of Patient Data from Uige, Angola". The Journal of Infectious Diseases 201 (12): 1909–1918. doi:10.1086/652748. PMID 20441515.
- ^ a b c Towner, J. S.; Amman, B. R.; Sealy, T. K.; Carroll, S. A. R.; Comer, J. A.; Kemp, A.; Swanepoel, R.; Paddock, C. D. et al. (2009). Fouchier, Ron A. M.. ed. "Isolation of Genetically Diverse Marburg Viruses from Egyptian Fruit Bats". PLoS Pathogens 5 (7): e1000536. doi:10.1371/journal.ppat.1000536. PMC 2713404. PMID 19649327. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2713404.
- ^ Adjemian, J.; Farnon, E. C.; Tschioko, F.; Wamala, J. F.; Byaruhanga, E.; Bwire, G. S.; Kansiime, E.; Kagirita, A. et al. (2011). "Outbreak of Marburg Hemorrhagic Fever Among Miners in Kamwenge and Ibanda Districts, Uganda, 2007". Journal of Infectious Diseases 204: S796–S799. doi:10.1093/infdis/jir312. PMID 21987753.
- ^ Timen, A.; Koopmans, M. P.; Vossen, A. C.; Van Doornum, G. J.; Günther, S.; Van Den Berkmortel, F.; Verduin, K. M.; Dittrich, S. et al. (2009). "Response to Imported Case of Marburg Hemorrhagic Fever, the Netherlands". Emerging infectious diseases 15 (8): 1171–1175. PMC 2815969. PMID 19751577. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2815969.
- ^ Pringle, C. R. (2005), "Order Mononegavirales", in Fauquet, C. M.; Mayo, M. A.; Maniloff, J. et al., Virus Taxonomy—Eighth Report of the International Committee on Taxonomy of Viruses, San Diego, USA: Elsevier/Academic Press, pp. 609–614, ISBN 0123702003
- ^ a b Kiley, M. P.; Bowen, E. T.; Eddy, G. A.; Isaäcson, M.; Johnson, K. M.; McCormick, J. B.; Murphy, F. A.; Pattyn, S. R. et al. (1982). "Filoviridae: A taxonomic home for Marburg and Ebola viruses?". Intervirology 18 (1–2): 24–32. PMID 7118520.
- ^ Geisbert, T. W.; Jahrling, P. B. (1995). "Differentiation of filoviruses by electron microscopy". Virus research 39 (2–3): 129–150. PMID 8837880.
- ^ a b c Alibek, Steven; Handelman, Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World - Told from Inside by the Man Who Ran It, New York, USA: Random House, ISBN 038533496-6
Further reading
- Klenk, Hans-Dieter (1999), Marburg and Ebola Viruses. Current Topics in Microbiology and Immunology, vol. 235, Berlin, Germany: Springer-Verlag, ISBN 978-3540647294
- Klenk, Hans-Dieter; Feldmann, Heinz (2004), Ebola and Marburg Viruses - Molecular and Cellular Biology, Wymondham, Norfolk, UK: Horizon Bioscience, ISBN 978-0954523237
- Kuhn, Jens H. (2008), Filoviruses - A Compendium of 40 Years of Epidemiological, Clinical, and Laboratory Studies. Archives of Virology Supplement, vol. 20, Vienna, Austria: SpringerWienNewYork, ISBN 978-3211206706
- Martini, G. A.; Siegert, R. (1971). Marburg Virus Disease. Berlin, Germany: Springer-Verlag. ISBN 978-0387051994.
- Ryabchikova, Elena I.; Price, Barbara B. (2004), Ebola and Marburg Viruses - A View of Infection Using Electron Microscopy, Columbus, Ohio, USA: Battelle Press, ISBN 978-1574771312
External links
Categories:- Animal diseases
- Animal virology
- Arthropod-borne viral fevers and viral haemorrhagic fevers
- Biological weapons
- Hemorrhagic fevers
- Mononegavirales
- Microbiology
- RNA viruses
- Tropical diseases
- Viral diseases
- Virology
- Virus-related cutaneous conditions
- Viruses
- Zoonoses
Wikimedia Foundation. 2010.